Viruses, Vol. 14, Pages 347: T Cell Response following Anti-COVID-19 BNT162b2 Vaccination Is Maintained against the SARS-CoV-2 Omicron B.1.1.529 Variant of Concern
Viruses doi: 10.3390/v14020347
Authors:
Hila Cohen
Shahar Rotem
Viruses, Vol. 14, Pages 347: T Cell Response following Anti-COVID-19 BNT162b2 Vaccination Is Maintained against the SARS-CoV-2 Omicron B.1.1.529 Variant of Concern
![24 Industry Picture for Application Page](https://ecsense.com/wp-content/uploads/2021/02/24-scaled.jpg)